Form 8-K - Current report:
SEC Accession No. 0001829126-25-008338
Filing Date
2025-10-22
Accepted
2025-10-22 16:09:13
Documents
13
Period of Report
2025-10-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K novabay_8k.htm   iXBRL 8-K 27542
2 EXHIBIT 3.1 novabay_ex3-1.htm EX-3.1 112423
  Complete submission text file 0001829126-25-008338.txt   330252

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE nby-20251016.xsd EX-101.SCH 2984
4 XBRL LABEL FILE nby-20251016_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE nby-20251016_pre.xml EX-101.PRE 22339
15 EXTRACTED XBRL INSTANCE DOCUMENT novabay_8k_htm.xml XML 3693
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 251410215
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)